Literature DB >> 9536325

Parathyroid hormone in the treatment of involutional osteoporosis: back to the future.

J Y Reginster1, A N Taquet, G Fraikin, C Gosset, B Zegels.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9536325     DOI： 10.1007/bf03194365

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  62 in total

Review 1.  Cellular and molecular mechanisms in the regulation and function of osteoclasts.

Authors:  T J Chambers; T J Hall
Journal:  Vitam Horm       Date:  1991       Impact factor: 3.421

2.  hPTH 1-34 treatment of osteoporosis with added hormone replacement therapy: biochemical, kinetic and histological responses.

Authors:  J Reeve; J N Bradbeer; M Arlot; U M Davies; J R Green; L Hampton; C Edouard; R Hesp; P Hulme; J P Ashby
Journal:  Osteoporos Int       Date:  1991-06       Impact factor: 4.507

3.  The risk of breast cancer after estrogen and estrogen-progestin replacement.

Authors:  L Bergkvist; H O Adami; I Persson; R Hoover; C Schairer
Journal:  N Engl J Med       Date:  1989-08-03       Impact factor: 91.245

4.  Effects of intermittent hPTH(1-34) alone and in combination with 1,25(OH)(2)D(3) or risedronate on endosteal bone remodeling in canine cancellous and cortical bone.

Authors:  R W Boyce; C L Paddock; A F Franks; M L Jankowsky; E F Eriksen
Journal:  J Bone Miner Res       Date:  1996-05       Impact factor: 6.741

5.  Inhibitory insulin-like growth factor-binding protein: cloning, complete sequence, and physiological regulation.

Authors:  D LaTour; S Mohan; T A Linkhart; D J Baylink; D D Strong
Journal:  Mol Endocrinol       Date:  1990-12

6.  Increase of whole-body calcium and skeletal mass in normal and osteoporotic adult rats treated with parathyroid hormone.

Authors:  E Hefti; U Trechsel; J P Bonjour; H Fleisch; R Schenk
Journal:  Clin Sci (Lond)       Date:  1982-04       Impact factor: 6.124

7.  Production of new trabecular bone in osteopenic ovariectomized rats by prostaglandin E2.

Authors:  S Mori; W S Jee; X J Li
Journal:  Calcif Tissue Int       Date:  1992-01       Impact factor: 4.333

8.  Increase of vertebral density by combination therapy with pulsatile 1-38hPTH and sequential addition of calcitonin nasal spray in osteoporotic patients.

Authors:  R D Hesch; U Busch; M Prokop; G Delling; E F Rittinghaus
Journal:  Calcif Tissue Int       Date:  1989-03       Impact factor: 4.333

9.  Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone.

Authors:  T L McCarthy; M Centrella; E Canalis
Journal:  Endocrinology       Date:  1989-03       Impact factor: 4.736

10.  Serum levels of intact parathyroid hormone and alkaline phosphatase correlate with cortical and trabecular bone loss in primary hyperparathyroidism.

Authors:  J Pfeilschifter; E Siegrist; C Wüster; E Blind; R Ziegler
Journal:  Acta Endocrinol (Copenh)       Date:  1992-10
View more
  4 in total

Review 1.  Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club.

Authors:  Steven Boonen; Jean-Jacques Body; Yves Boutsen; Jean-Pierre Devogelaer; Stefan Goemaere; Jean-Marc Kaufman; Serge Rozenberg; Jean-Yves Reginster
Journal:  Osteoporos Int       Date:  2005-01-26       Impact factor: 4.507

2.  Osteoporosis Update 1997. Symposium proceedings. Osaka, Japan, 13-16 November 1997.

Authors: 
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 3.  Current, new and future treatments of osteoporosis.

Authors:  Pooneh Salari Sharif; Mohammad Abdollahi; Bagher Larijani
Journal:  Rheumatol Int       Date:  2010-07-30       Impact factor: 2.631

Review 4.  Progress in osteoporosis and fracture prevention: focus on postmenopausal women.

Authors:  Kenneth G Saag; Piet Geusens
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.